Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke

scientific article published on February 22, 1992

Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0140-6736(92)91057-F
P698PubMed publication ID1346819

P2093author name stringP. Smith
M. Abdelnoor
H. Arnesen
F. Wisløff
K. E. Sletnes
P433issue8791
P407language of work or nameEnglishQ1860
P921main subjectmyocardial infarctionQ12152
P304page(s)451-453
P577publication date1992-02-01
1992-02-22
P1433published inThe LancetQ939416
P1476titleAntiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke
P478volume339

Reverse relations

cites work (P2860)
Q37790448A review of hereditary and acquired coagulation disorders in the aetiology of ischaemic stroke
Q44234343Annexin V levels in survivors of early myocardial infarction
Q41673431Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease
Q71691168Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study
Q55365972Anticardiolipin antibodies and cardiovascular disease.
Q33612761Anticardiolipin antibodies in ischaemic heart disease: marker or myth?
Q71482152Antiphospholipid antibodies in heart transplant recipients
Q40583128Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus: a unifying 'membrane stress syndrome' hypothesis
Q34331685Antiphospholipid syndrome; its implication in cardiovascular diseases: a review
Q33890407Autoantibodies to modified LDLs and other phospholipid-protein complexes as markers of cardiovascular diseases
Q36283448Cardiac involvement in the antiphospholipid syndrome
Q61914430Chapter 8 Systemic Manifestations of the Antiphospholipid Syndrome
Q40529762Clinical and therapeutic aspects of the antiphospholipid syndrome
Q33490045Clinical trials on antiphospholipid syndrome: what is being done and what is needed?
Q40519206Clinicopathologic correlations of the antiphospholipid syndrome
Q40887411Heterogeneity of autoantibodies against cardiolipin and oxidatively modified LDLs revealed by human monoclonal antibodies
Q26750752Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis
Q33492572Importance of serum anticardiolipin antibody levels in coronary heart disease
Q37244413Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction
Q61943926LUPUS ANTICOAGULANTS AND ANTIPHOSPHOLIPID ANTIBODIES
Q58854434Lymphomes malins et syndrome des antiphospholipides non simultanés : quatre observations
Q71112355Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry
Q35008513Phospholipid autoantibodies: time for a new immuno-assay?
Q37775992Screening for coagulation disorders in patients with ischemic stroke
Q35189292Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002.
Q34151618The clinical significance of antiphospholipid antibodies in patients without autoimmune disease
Q37959884The management of stroke in antiphospholipid syndrome
Q35683321The role of endothelial cell reactive antibodies in peripheral vascular disease
Q35610110Thrombophilia and stroke
Q74521081[Pathology of diseases of extracardiac origin. VI. Disease of the connective tissue and heart]
Q73960298[Prevalence of antiphospholipid syndrome in patients under 65 years of age with acute myocardial infarction]

Search more.